The Resource Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta
Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta
Resource Information
The item Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Missouri University of Science & Technology Library.This item is available to borrow from 1 library branch.
Resource Information
The item Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in Missouri University of Science & Technology Library.
This item is available to borrow from 1 library branch.
- Summary
- Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of biomarkers in therapeutic drug monitoring. This reference also discusses the limitations of current commercially available immunoassays for therapeutic monitoring. It presents€new and sophisticated techniques used for proper determination of blood levels and the clinical utility of therapeutic drug monitoring of contemporary drugs. Written by leading international experts and geared toward clinical pathol
- Language
- eng
- Extent
- 1 online resource (vii, 459 pages)
- Contents
-
- Front matter
- Copyright
- Contributers
- Chapter 1. Introduction to therapeutic drug monitoring: frequently and less frequently monitored drugs
- Chapter 2. Effects of pre-analytical variables in therapeutic drug monitoring
- Chapter 3. Analytical techniques used in therapeutic drug monitoring
- Chapter 4. Clinical utility of free drug monitoring
- Chapter 5. Current practice of therapeutic drug monitoring: dose adjustment of drugs using pharmacokinetic models
- Chapter 6. An introduction to personalized medicine
- Chapter 7. Application of ultra-high throughput sequencing and microarray technologies in pharmacogenomics testing
- Chapter 8. Pharmacogenomics and Warfarin therapy
- Chapter 9. Applications of pharmacokinetic and pharmacodynamic principles to optimize drug dosage selection: example of antibiotic therapy management
- Chapter 10. Guidelines for the monitoring of vancomycin, aminoglycosides and certain antibiotics
- Chapter 11. Challenges in therapeutic drug monitoring of digoxin and other anti-arrhythmic drugs
- Chapter 12. Therapeutic drug monitoring of classical and newer anticonvulsants
- Chapter 13. Challenges in therapeutic drug monitoring of classical tricyclic and newer antidepressants: analytical and pharmacogenetics considerations
- Chapter 14. Therapeutic drug monitoring of selected anticancer drugs: pharmacogenomics issues
- Chapter 15. Immunosuppressive drug monitoring: limitations of immunoassays and the application of liquid chromatography mass spectrometry
- Chapter 16. Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics of immunosuppressants
- Chapter 17. Therapeutic drug monitoring of antiretroviral drugs in the management of human immunodeficiency virus infection
- Chapter 18. Drug testing in pain management
- Chapter 19. Effect of herbal supplement-drug interactions on therapeutic drug monitoring
- Index
- Isbn
- 9780123854681
- Label
- Therapeutic drug monitoring : newer drugs and biomarkers
- Title
- Therapeutic drug monitoring
- Title remainder
- newer drugs and biomarkers
- Statement of responsibility
- edited by Amitava Dasgupta
- Subject
-
- Pharmacokinetics
- Biochemical markers
- Biochemical markers
- Biological monitoring
- Biological monitoring
- Chemotherapy
- Chemotherapy
- Drug Monitoring -- methods
- Drug monitoring
- Drug monitoring
- Drugs -- Analysis
- Drugs -- Analysis
- Electronic books
- MEDICAL -- Chemotherapy
- Pharmaceutical Preparations -- standards
- Pharmacokinetics
- Language
- eng
- Summary
- Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of biomarkers in therapeutic drug monitoring. This reference also discusses the limitations of current commercially available immunoassays for therapeutic monitoring. It presents€new and sophisticated techniques used for proper determination of blood levels and the clinical utility of therapeutic drug monitoring of contemporary drugs. Written by leading international experts and geared toward clinical pathol
- Cataloging source
- EBLCP
- Dewey number
-
- 615.5/8
- 615.58
- Illustrations
- illustrations
- Index
- index present
- LC call number
- RM301.9
- Literary form
- non fiction
- Nature of contents
-
- dictionaries
- bibliography
- http://library.link/vocab/relatedWorkOrContributorDate
- 1958-
- http://library.link/vocab/relatedWorkOrContributorName
- Dasgupta, Amitava
- http://library.link/vocab/subjectName
-
- Drug monitoring
- Chemotherapy
- Biochemical markers
- Biological monitoring
- Drugs
- Pharmacokinetics
- Drug Monitoring
- Pharmaceutical Preparations
- MEDICAL
- Biochemical markers
- Biological monitoring
- Chemotherapy
- Drug monitoring
- Drugs
- Pharmacokinetics
- Label
- Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta
- Antecedent source
- unknown
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Front matter -- Copyright -- Contributers -- Chapter 1. Introduction to therapeutic drug monitoring: frequently and less frequently monitored drugs -- Chapter 2. Effects of pre-analytical variables in therapeutic drug monitoring -- Chapter 3. Analytical techniques used in therapeutic drug monitoring -- Chapter 4. Clinical utility of free drug monitoring -- Chapter 5. Current practice of therapeutic drug monitoring: dose adjustment of drugs using pharmacokinetic models -- Chapter 6. An introduction to personalized medicine -- Chapter 7. Application of ultra-high throughput sequencing and microarray technologies in pharmacogenomics testing -- Chapter 8. Pharmacogenomics and Warfarin therapy -- Chapter 9. Applications of pharmacokinetic and pharmacodynamic principles to optimize drug dosage selection: example of antibiotic therapy management -- Chapter 10. Guidelines for the monitoring of vancomycin, aminoglycosides and certain antibiotics -- Chapter 11. Challenges in therapeutic drug monitoring of digoxin and other anti-arrhythmic drugs -- Chapter 12. Therapeutic drug monitoring of classical and newer anticonvulsants -- Chapter 13. Challenges in therapeutic drug monitoring of classical tricyclic and newer antidepressants: analytical and pharmacogenetics considerations -- Chapter 14. Therapeutic drug monitoring of selected anticancer drugs: pharmacogenomics issues -- Chapter 15. Immunosuppressive drug monitoring: limitations of immunoassays and the application of liquid chromatography mass spectrometry -- Chapter 16. Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics of immunosuppressants -- Chapter 17. Therapeutic drug monitoring of antiretroviral drugs in the management of human immunodeficiency virus infection -- Chapter 18. Drug testing in pain management -- Chapter 19. Effect of herbal supplement-drug interactions on therapeutic drug monitoring -- Index
- Control code
- 795120450
- Dimensions
- unknown
- Extent
- 1 online resource (vii, 459 pages)
- File format
- unknown
- Form of item
- online
- Isbn
- 9780123854681
- Level of compression
- unknown
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Other physical details
- illustrations
- http://library.link/vocab/ext/overdrive/overdriveId
- 08f5f060-f460-48b1-b2ce-dcde2b36a6d3
- Quality assurance targets
- unknown
- Reformatting quality
- unknown
- Specific material designation
- remote
- System control number
- (OCoLC)795120450
- Label
- Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta
- Antecedent source
- unknown
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Front matter -- Copyright -- Contributers -- Chapter 1. Introduction to therapeutic drug monitoring: frequently and less frequently monitored drugs -- Chapter 2. Effects of pre-analytical variables in therapeutic drug monitoring -- Chapter 3. Analytical techniques used in therapeutic drug monitoring -- Chapter 4. Clinical utility of free drug monitoring -- Chapter 5. Current practice of therapeutic drug monitoring: dose adjustment of drugs using pharmacokinetic models -- Chapter 6. An introduction to personalized medicine -- Chapter 7. Application of ultra-high throughput sequencing and microarray technologies in pharmacogenomics testing -- Chapter 8. Pharmacogenomics and Warfarin therapy -- Chapter 9. Applications of pharmacokinetic and pharmacodynamic principles to optimize drug dosage selection: example of antibiotic therapy management -- Chapter 10. Guidelines for the monitoring of vancomycin, aminoglycosides and certain antibiotics -- Chapter 11. Challenges in therapeutic drug monitoring of digoxin and other anti-arrhythmic drugs -- Chapter 12. Therapeutic drug monitoring of classical and newer anticonvulsants -- Chapter 13. Challenges in therapeutic drug monitoring of classical tricyclic and newer antidepressants: analytical and pharmacogenetics considerations -- Chapter 14. Therapeutic drug monitoring of selected anticancer drugs: pharmacogenomics issues -- Chapter 15. Immunosuppressive drug monitoring: limitations of immunoassays and the application of liquid chromatography mass spectrometry -- Chapter 16. Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics of immunosuppressants -- Chapter 17. Therapeutic drug monitoring of antiretroviral drugs in the management of human immunodeficiency virus infection -- Chapter 18. Drug testing in pain management -- Chapter 19. Effect of herbal supplement-drug interactions on therapeutic drug monitoring -- Index
- Control code
- 795120450
- Dimensions
- unknown
- Extent
- 1 online resource (vii, 459 pages)
- File format
- unknown
- Form of item
- online
- Isbn
- 9780123854681
- Level of compression
- unknown
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Other physical details
- illustrations
- http://library.link/vocab/ext/overdrive/overdriveId
- 08f5f060-f460-48b1-b2ce-dcde2b36a6d3
- Quality assurance targets
- unknown
- Reformatting quality
- unknown
- Specific material designation
- remote
- System control number
- (OCoLC)795120450
Subject
- Pharmacokinetics
- Biochemical markers
- Biochemical markers
- Biological monitoring
- Biological monitoring
- Chemotherapy
- Chemotherapy
- Drug Monitoring -- methods
- Drug monitoring
- Drug monitoring
- Drugs -- Analysis
- Drugs -- Analysis
- Electronic books
- MEDICAL -- Chemotherapy
- Pharmaceutical Preparations -- standards
- Pharmacokinetics
Genre
Member of
Library Links
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.mst.edu/portal/Therapeutic-drug-monitoring--newer-drugs-and/KacmaunBb5M/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.mst.edu/portal/Therapeutic-drug-monitoring--newer-drugs-and/KacmaunBb5M/">Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.mst.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.mst.edu/">Missouri University of Science & Technology Library</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.mst.edu/portal/Therapeutic-drug-monitoring--newer-drugs-and/KacmaunBb5M/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.mst.edu/portal/Therapeutic-drug-monitoring--newer-drugs-and/KacmaunBb5M/">Therapeutic drug monitoring : newer drugs and biomarkers, edited by Amitava Dasgupta</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.mst.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.mst.edu/">Missouri University of Science & Technology Library</a></span></span></span></span></div>
